わが国における薬剤による有害事象に関する判例の検討：判例誌掲載例の分類

DOI Web Site Web Site PubMed 被引用文献1件 参考文献8件

書誌事項

タイトル別名
  • A Systematic Review of Decided Litigated Cases on Adverse Drug Events in Japan: Classification of Decided Cases Appearing in Law Reports
  • ワガクニ ニ オケル ヤクザイ ニ ヨル ユウガイ ジショウ ニ カンスル ハンレイ ノ ケントウ : ハンレイシ ケイサイレイ ノ ブンルイ

この論文をさがす

抄録

  Much of the damage to health caused by drugs could be prevented by appropriate care. A well-defined duty of care and further information are required for healthcare professionals. Although there are many litigation cases to use as references, neither the extent of the duty of care nor the obligation to explain medication according to the type of drug prescribed has yet been fully established. Thus, we systematically collected decided cases of adverse drug events, and assessed the degree of the duties of care and information. Specifically, we collected decided cases in which physicians, dentists, pharmacists, nurses, or hospitals had been sued. Data were derived from Bessatsu Jurist Iryo-kago Hanrei Hyakusen, Hanrei Jihou, and Hanrei Times from 1989 to November 2013, and information on precedents in the records of the Supreme Court of Japan from 2001 to November 2013. We analyzed the cases, and assessed the following according to the type of drug: (1) standards and explanations when dealing with drugs that were critical issues in litigation, and (2) the degree of the physician's or pharmacist's duties of care and information. In total, 126 cases were collected. The number of drug categories classified was 27, and 9 were considered of practical importance. After this systematic review, we found a trend in the degree of the required level of care and information on several drugs. With respect to duties of care and information, the gap between the required level and actual practice suggests that healthcare professionals must improve their care and explanations.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 135 (3), 501-506, 2015-03-01

    公益社団法人 日本薬学会

被引用文献 (1)*注記

もっと見る

参考文献 (8)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ